{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T01:02:36Z","timestamp":1789434156224,"version":"build-2803163510"},"reference-count":74,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T00:00:00Z","timestamp":1782172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T00:00:00Z","timestamp":1789430400000},"content-version":"vor","delay-in-days":84,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-58527-6","type":"journal-article","created":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T00:36:56Z","timestamp":1782175016000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Losartan shows limited benefit in preclinical models of Geleophysic dysplasia"],"prefix":"10.1038","volume":"16","author":[{"given":"Alejo A.","family":"Morales","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladimir","family":"Camarena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L\u00e9Shon","family":"Peart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Smithson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherina","family":"Walz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaofeng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mustafa","family":"Tekin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,23]]},"reference":[{"key":"58527_CR1","unstructured":"Marzin, P. & Cormier-Daire, V. Geleophysic dysplasia. In GeneReviews\u00ae [Internet]  (eds. Adam M. P. et al.)  (University of Washington,  1993)."},{"key":"58527_CR2","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/S0140-6736(71)92073-3","volume":"2","author":"JW Spranger","year":"1971","unstructured":"Spranger, J. W., Gilbert, E. F., Tuffli, G. A., Rossiter, F. P. & Opitz, J. M. Geleophysic dwarfism\u2014a focal mucopolysaccharidosis? Lancet 2, 97\u201398 (1971).","journal-title":"Lancet"},{"key":"58527_CR3","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1002\/ajmg.1320190310","volume":"19","author":"J Spranger","year":"1984","unstructured":"Spranger, J., Gilbert, E. F., Arya, S., Hoganson, G. M. I. & Opitz, J. M. Geleophysic dysplasia. Am. J. Med. Genet. 19, 487\u2013499 (1984).","journal-title":"Am. J. Med. Genet."},{"key":"58527_CR4","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1002\/ajmg.1320280522","volume":"3","author":"AH Lipson","year":"1987","unstructured":"Lipson, A. H., Kan, A. E. & Kozlowski, K. Geleophysic dysplasia\u2014acromicric dysplasia with evidence of glycoprotein storage. Am. J. Med. Genet. Suppl. 3, 181\u2013189 (1987).","journal-title":"Am. J. Med. Genet. Suppl."},{"key":"58527_CR5","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1002\/ajmg.1320350202","volume":"35","author":"JE Wraith","year":"1990","unstructured":"Wraith, J. E., Bankier, A., Chow, C. W., Danks, D. M. & Sardharwalla, I. B. Geleophysic dysplasia. Am. J. Med. Genet. 35, 153\u2013156 (1990).","journal-title":"Am. J. Med. Genet."},{"key":"58527_CR6","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1136\/jmg.2010.087544","volume":"48","author":"S Allali","year":"2011","unstructured":"Allali, S. et al. Molecular screening of ADAMTSL2 gene in 33 patients reveals the genetic heterogeneity of geleophysic dysplasia. J. Med. Genet. 48, 417\u2013421 (2011).","journal-title":"J. Med. Genet."},{"key":"58527_CR7","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1038\/s41436-020-00994-x","volume":"23","author":"P Marzin","year":"2021","unstructured":"Marzin, P. et al. Geleophysic and acromicric dysplasias: natural history, genotype-phenotype correlations, and management guidelines from 38 cases. Genet. Med. 23, 331\u2013340 (2021).","journal-title":"Genet. Med."},{"key":"58527_CR8","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1038\/ng.199","volume":"40","author":"C Le Goff","year":"2008","unstructured":"Le Goff, C. et al. ADAMTSL2 mutations in geleophysic dysplasia demonstrate a role for ADAMTS-like proteins in TGF-beta bioavailability regulation. Nat. Genet. 40, 1119\u20131123 (2008).","journal-title":"Nat. Genet."},{"key":"58527_CR9","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.ajhg.2011.05.012","volume":"89","author":"C Le Goff","year":"2011","unstructured":"Le Goff, C. et al. Mutations in the TGF\u03b2 binding-protein-like domain 5 of FBN1 are responsible for acromicric and geleophysic dysplasias. Am. J. Hum. Genet. 89, 7\u201314 (2011).","journal-title":"Am. J. Hum. Genet."},{"key":"58527_CR10","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1136\/jmedgenet-2015-103647","volume":"53","author":"AM McInerney-Leo","year":"2016","unstructured":"McInerney-Leo, A. M. et al. Mutations in LTBP3 cause acromicric dysplasia and geleophysic dysplasia. J. Med. Genet. 53, 457\u2013464 (2016).","journal-title":"J. Med. Genet."},{"key":"58527_CR11","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.matbio.2007.03.003","volume":"26","author":"BH Koo","year":"2007","unstructured":"Koo, B. H. et al. ADAMTS-like 2 (ADAMTSL2) is a secreted glycoprotein that is widely expressed during mouse embryogenesis and is regulated during skeletal myogenesis. Matrix Biol. 26, 431\u2013441 (2007).","journal-title":"Matrix Biol."},{"key":"58527_CR12","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.matbio.2018.06.002","volume":"71\u201372","author":"TJ Mead","year":"2018","unstructured":"Mead, T. J. & Apte, S. S. ADAMTS proteins in human disorders. Matrix Biol. 71\u201372, 225\u2013239 (2018).","journal-title":"Matrix Biol."},{"key":"58527_CR13","doi-asserted-by":"publisher","first-page":"15742","DOI":"10.1074\/jbc.RA120.014557","volume":"295","author":"A Zhang","year":"2020","unstructured":"Zhang, A. et al. O-Fucosylation of ADAMTSL2 is required for secretion and is impacted by geleophysic dysplasia-causing mutations. J. Biol. Chem. 295, 15742\u201315753 (2020).","journal-title":"J. Biol. Chem."},{"key":"58527_CR14","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.matbio.2015.05.004","volume":"47","author":"D Hubmacher","year":"2015","unstructured":"Hubmacher, D. & Apte, S. S. ADAMTS proteins as modulators of microfibril formation and function. Matrix Biol. 47, 34\u201343 (2015).","journal-title":"Matrix Biol."},{"key":"58527_CR15","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1242\/dmm.017046","volume":"8","author":"D Hubmacher","year":"2015","unstructured":"Hubmacher, D., Wang, L. W., Mecham, R. P., Reinhardt, D. P. & Apte, S. S. Adamtsl2 deletion results in bronchial fibrillin microfibril accumulation and bronchial epithelial dysplasia\u2014 a novel mouse model providing insights into geleophysic dysplasia. Dis. Model. Mech. 8, 487\u2013499 (2015).","journal-title":"Dis. Model. Mech."},{"key":"58527_CR16","doi-asserted-by":"publisher","first-page":"2707","DOI":"10.1096\/fj.201800753RR","volume":"33","author":"L Delhon","year":"2019","unstructured":"Delhon, L. et al. Impairment of chondrogenesis and microfibrillar network in Adamtsl2 deficiency. FASEB J. 33, 2707\u20132718 (2019).","journal-title":"FASEB J."},{"key":"58527_CR17","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.semcdb.2018.07.016","volume":"89","author":"J Thomson","year":"2019","unstructured":"Thomson, J. et al. Fibrillin microfibrils and elastic fibre proteins: functional interactions and extracellular regulation of growth factors. Semin Cell. Dev. Biol. 89, 109\u2013117 (2019).","journal-title":"Semin Cell. Dev. Biol."},{"key":"58527_CR18","doi-asserted-by":"publisher","first-page":"19757","DOI":"10.1038\/s41598-021-99032-2","volume":"11","author":"KB Rypdal","year":"2021","unstructured":"Rypdal, K. B. et al. The extracellular matrix glycoprotein ADAMTSL2 is increased in heart failure and inhibits TGF\u03b2 signalling in cardiac fibroblasts. Sci. Rep. 11, 19757 (2021).","journal-title":"Sci. Rep."},{"issue":"3","key":"58527_CR19","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1083\/jcb.200608167","volume":"176","author":"SS Chaudhry","year":"2007","unstructured":"Chaudhry, S. S. et al. Fibrillin-1 regulates the bioavailability of TGFbeta1. J. Cell. Biol. 176 (3), 355\u2013367 (2007).","journal-title":"J. Cell. Biol."},{"key":"58527_CR20","doi-asserted-by":"publisher","first-page":"2499","DOI":"10.1083\/jcb.103.6.2499","volume":"103","author":"LY Sakai","year":"1986","unstructured":"Sakai, L. Y., Keene, D. R. & Engvall, E. Fibrillin, a new 350-kD glycoprotein, is a component of extracellular microfibrils. J. Cell. Biol. 103, 2499\u20132509 (1986).","journal-title":"J. Cell. Biol."},{"key":"58527_CR21","doi-asserted-by":"publisher","first-page":"14763","DOI":"10.1016\/S0021-9258(18)98752-1","volume":"266","author":"LY Sakai","year":"1991","unstructured":"Sakai, L. Y., Keene, D. R., Glanville, R. W. & Bachinger, H. P. Purification and partial characterization of fibrillin, a cysteine-rich structural component of connective tissue microfibrils. J. Biol. Chem. 266, 14763\u201314770 (1991).","journal-title":"J. Biol. Chem."},{"key":"58527_CR22","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1006\/geno.1993.1350","volume":"17","author":"GM Corson","year":"1993","unstructured":"Corson, G. M., Chalberg, S. C., Dietz, H. C., Charbonneau, N. L. & Sakai, L. Y. Fibrillin binds calcium and is coded by cDNAs that reveal a multidomain structure and alternatively spliced exons at the 5-prime end. Genomics 17, 476\u2013484 (1993).","journal-title":"Genomics"},{"issue":"17","key":"58527_CR23","doi-asserted-by":"publisher","first-page":"3006","DOI":"10.1242\/jcs.073437","volume":"123","author":"T Massam-Wu","year":"2010","unstructured":"Massam-Wu, T. et al. Assembly of fibrillin microfibrils governs extracellular deposition of latent TGF beta. J. Cell. Sci. 123 (17), 3006\u20133018 (2010).","journal-title":"J. Cell. Sci."},{"key":"58527_CR24","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.matbio.2022.01.005","volume":"107","author":"MP Lockhart-Cairns","year":"2022","unstructured":"Lockhart-Cairns, M. P. et al. Latent TGF\u03b2 complexes are transglutaminase cross-linked to fibrillin to facilitate TGF\u03b2 activation. Matrix Biol. 107, 24\u201339 (2022).","journal-title":"Matrix Biol."},{"issue":"4","key":"58527_CR25","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1002\/(SICI)1098-1004(1997)10:4<280::AID-HUMU3>3.0.CO;2-L","volume":"10","author":"C Hayward","year":"1997","unstructured":"Hayward, C., Porteous, M. E. & Brock, D. J. Mutation screening of all 65 exons of the fibrillin-1 gene in 60 patients with Marfan syndrome: report of 12 novel mutations. Hum. Mutat. 10 (4), 280\u2013289 (1997).","journal-title":"Hum. Mutat."},{"issue":"3","key":"58527_CR26","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1002\/humu.10249","volume":"22","author":"G Collod-B\u00e9roud","year":"2003","unstructured":"Collod-B\u00e9roud, G. et al. Update of the UMD-FBN1 mutation database and creation of an FBN1 polymorphism database. Hum. Mutat. 22 (3), 199\u2013208 (2003).","journal-title":"Hum. Mutat."},{"issue":"2","key":"58527_CR27","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/S1359-6101(99)00010-6","volume":"10","author":"J Saharinen","year":"1999","unstructured":"Saharinen, J., Hyyti\u00e4inen, M., Taipale, J. & Keski-Oja, J. Latent transforming growth factor-beta binding proteins (LTBPs)\u2014structural extracellular matrix proteins for targeting TGF-beta action. Cytokine Growth Factor. Rev. 10 (2), 99\u2013117 (1999).","journal-title":"Cytokine Growth Factor. Rev."},{"issue":"17","key":"58527_CR28","doi-asserted-by":"publisher","first-page":"3457","DOI":"10.1242\/jcs.115.17.3457","volume":"115","author":"C Penttinen","year":"2002","unstructured":"Penttinen, C., Saharinen, J., Weikkolainen, K., Hyyti\u00e4inen, M. & Keski-Oja, J. Secretion of human latent TGF-beta-binding protein-3 (LTBP-3) is dependent on co-expression of TGF-beta. J. Cell. Sci. 115 (17), 3457\u20133468 (2002).","journal-title":"J. Cell. Sci."},{"issue":"6","key":"58527_CR29","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1002\/ajmg.a.37049","volume":"167","author":"SL Dugan","year":"2015","unstructured":"Dugan, S. L. et al. New recessive truncating mutation in LTBP3 in a family with oligodontia, short stature, and mitral valve prolapse. Am. J. Med. Genet. A. 167 (6), 1396\u20131399 (2015).","journal-title":"Am. J. Med. Genet. A"},{"key":"58527_CR30","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1007\/s00438-019-01547-x","volume":"294","author":"N Intarak","year":"2019","unstructured":"Intarak, N. et al. Genotype\u2013phenotype correlation and expansion of orodental anomalies in LTBP3-related disorders. Mol. Genet. Genom. 294, 773\u2013787 (2019).","journal-title":"Mol. Genet. Genom"},{"issue":"5","key":"58527_CR31","doi-asserted-by":"publisher","first-page":"e174417","DOI":"10.1172\/jci.insight.174417","volume":"9","author":"V Camarena","year":"2024","unstructured":"Camarena, V. et al. ADAMTSL2 mutations determine the phenotypic severity in geleophysic dysplasia. JCI Insight. 9 (5), e174417 (2024).","journal-title":"JCI Insight"},{"issue":"7","key":"58527_CR32","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1093\/hmg\/ddg081","volume":"12","author":"P Whiteman","year":"2003","unstructured":"Whiteman, P. & Handford, P. A. Defective secretion of recombinant fragments of fibrillin-1: implications of protein misfolding for the pathogenesis of Marfan syndrome and related disorders. Hum. Mol. Genet. 12 (7), 727\u2013737 (2003).","journal-title":"Hum. Mol. Genet."},{"key":"58527_CR33","first-page":"100504","volume":"21","author":"P Piccolo","year":"2019","unstructured":"Piccolo, P. et al. Geleophysic dysplasia: novel missense variants and insights into ADAMTSL2 intracellular trafficking. Mol. Genet. Metab. Rep. 21, 100504 (2019).","journal-title":"Mol. Genet. Metab. Rep."},{"issue":"9","key":"58527_CR34","doi-asserted-by":"publisher","first-page":"e844","DOI":"10.1002\/mgg3.844","volume":"7","author":"P Piccolo","year":"2019","unstructured":"Piccolo, P. et al. Skin fibroblasts of patients with geleophysic dysplasia due to FBN1 mutations have lysosomal inclusions and losartan improves their microfibril deposition defect. Mol. Genet. Genomic Med. 7 (9), e844 (2019).","journal-title":"Mol. Genet. Genomic Med."},{"issue":"51","key":"58527_CR35","doi-asserted-by":"publisher","first-page":"e41000","DOI":"10.1097\/MD.0000000000041000","volume":"103","author":"J Liang","year":"2024","unstructured":"Liang, J. et al. Expanded phenotypes and pathogenesis of geleophysic dysplasia 3 resulted from a de novo LTBP3 mutation: A case report. Med. (Baltim). 103 (51), e41000 (2024).","journal-title":"Med. (Baltim)."},{"issue":"1","key":"58527_CR36","doi-asserted-by":"publisher","first-page":"19970","DOI":"10.1038\/s41598-025-04666-1","volume":"15","author":"AA Morales","year":"2025","unstructured":"Morales, A. A. et al. Dysregulation of cell migration by matrix metalloproteinases in geleophysic dysplasia. Sci. Rep. 15 (1), 19970 (2025).","journal-title":"Sci. Rep."},{"key":"58527_CR37","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.matbio.2023.05.003","volume":"120","author":"N Taye","year":"2023","unstructured":"Taye, N., Singh, M., Baldock, C. & Hubmacher, D. Secreted ADAMTS-like 2 promotes myoblast differentiation by potentiating WNT signaling. Matrix Biol. 120, 24\u201342 (2023).","journal-title":"Matrix Biol."},{"issue":"5770","key":"58527_CR38","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1126\/science.1124287","volume":"312","author":"JP Habashi","year":"2006","unstructured":"Habashi, J. P. et al. Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of Marfan syndrome. Science 312 (5770), 117\u2013121 (2006).","journal-title":"Science"},{"issue":"2","key":"58527_CR39","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.jtcvs.2009.10.039","volume":"140","author":"HH Yang","year":"2010","unstructured":"Yang, H. H., Kim, J. M., Chum, E., van Breemen, C. & Chung, A. W. Effectiveness of combination of losartan potassium and doxycycline versus single-drug treatments in the secondary prevention of thoracic aortic aneurysm in Marfan syndrome. J. Thorac. Cardiovasc. Surg. 140 (2), 305\u2013312 (2010).","journal-title":"J. Thorac. Cardiovasc. Surg."},{"issue":"4","key":"58527_CR40","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1002\/(SICI)1096-9926(199604)53:4<245::AID-TERA7>3.0.CO;2-1","volume":"53","author":"SG Spence","year":"1996","unstructured":"Spence, S. G. et al. Toxicokinetic analysis of losartan during gestation and lactation in the rat. Teratology 53 (4), 245\u2013252 (1996).","journal-title":"Teratology"},{"key":"58527_CR41","unstructured":"Patel, P. & Launico, M. V. Angiotensin II Receptor Blockers (ARB). In StatPearls [Internet] (StatPearls Publishing, 2025).  https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK537027\/."},{"issue":"6","key":"58527_CR42","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1002\/tera.1420510604","volume":"51","author":"SG Spence","year":"1995","unstructured":"Spence, S. G., Cukierski, M. A., Manson, J. M., Robertson, R. T. & Eydelloth, R. S. Evaluation of the reproductive and developmental toxicity of the AT1-selective angiotensin II receptor antagonist losartan in rats. Teratology 51 (6), 383\u2013397 (1995).","journal-title":"Teratology"},{"issue":"9253","key":"58527_CR43","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/S0140-6736(00)03648-5","volume":"357","author":"H Saji","year":"2001","unstructured":"Saji, H., Yamanaka, M., Hagiwara, A. & Ijiri, R. Losartan and fetal toxic effects. Lancet 357 (9253), 363 (2001).","journal-title":"Lancet"},{"issue":"9277","key":"58527_CR44","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/S0140-6736(01)05426-5","volume":"358","author":"J Martinovic","year":"2001","unstructured":"Martinovic, J., Benachi, A., Laurent, N., Daikha-Dahmane, F. & Gubler, M. C. Fetal toxic effects and angiotensin-II-receptor antagonists. Lancet 358 (9277), 241\u2013242 (2001).","journal-title":"Lancet"},{"issue":"6","key":"58527_CR45","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1023\/A:1020884312053","volume":"32","author":"AA Bachmanov","year":"2002","unstructured":"Bachmanov, A. A., Reed, D. R., Beauchamp, G. K. & Tordoff, M. G. Food intake, water intake, and drinking spout side preference of 28 mouse strains. Behav. Genet. 32 (6), 435\u2013443 (2002).","journal-title":"Behav. Genet."},{"key":"58527_CR46","unstructured":"Wimer, R. E. & Fuller, J. L. Patterns of behavior. In   Biology of the Laboratory Mouse (ed. Green, E. L.) 629\u2013653 (McGraw-Hill, 1966)."},{"issue":"10","key":"58527_CR47","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.1097\/01.hjh.0000182521.44440.c5","volume":"23","author":"P Lavoie","year":"2005","unstructured":"Lavoie, P. et al. Neutralization of transforming growth factor-beta attenuates hypertension and prevents renal injury in uremic rats. J. Hypertens. 23 (10), 1895\u20131903 (2005).","journal-title":"J. Hypertens."},{"issue":"6","key":"58527_CR48","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1161\/01.CIR.103.6.789","volume":"103","author":"DS Lim","year":"2001","unstructured":"Lim, D. S. et al. Angiotensin II blockade reverses myocardial fibrosis in a transgenic mouse model of human hypertrophic cardiomyopathy. Circulation 103 (6), 789\u2013791 (2001).","journal-title":"Circulation"},{"issue":"3","key":"58527_CR49","first-page":"R624","volume":"277","author":"LG Melo","year":"1999","unstructured":"Melo, L. G., Veress, A. T., Chong, C. K., Ackermann, U. & Sonnenberg, H. Salt-sensitive hypertension in ANP knockout mice is prevented by AT1 receptor antagonist losartan. Am. J. Physiol. 277 (3), R624\u2013R630 (1999).","journal-title":"Am. J. Physiol."},{"issue":"22","key":"58527_CR50","doi-asserted-by":"publisher","first-page":"6889","DOI":"10.1128\/MCB.01192-08","volume":"28","author":"AC Daly","year":"2008","unstructured":"Daly, A. C., Randall, R. A. & Hill, C. S. Transforming growth factor beta-induced Smad1\/5 phosphorylation in epithelial cells is mediated by novel receptor complexes and is essential for anchorage-independent growth. Mol. Cell. Biol. 28 (22), 6889\u20136902 (2008).","journal-title":"Mol. Cell. Biol."},{"issue":"1","key":"58527_CR51","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s12964-025-02051-z","volume":"23","author":"YW Wang","year":"2025","unstructured":"Wang, Y. W. & Luo, C. W. Unveiling the signal valve specifically tuning the TGF-\u03b21 suppression of osteogenesis: mediation through a SMAD1-SMAD2 complex. Cell. Commun. Signal. 23 (1), 38 (2025).","journal-title":"Cell. Commun. Signal."},{"key":"58527_CR52","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.matbio.2022.08.001","volume":"112","author":"K Singh","year":"2022","unstructured":"Singh, K., Sachan, N., Ene, T., Dabovic, B. & Rifkin, D. Latent transforming growth factor \u03b2 binding protein 3 controls adipogenesis. Matrix Biol. 112, 155\u2013170 (2022).","journal-title":"Matrix Biol."},{"issue":"6","key":"58527_CR53","doi-asserted-by":"publisher","first-page":"112712","DOI":"10.1016\/j.isci.2025.112712","volume":"28","author":"C Redhead","year":"2025","unstructured":"Redhead, C. et al. The matricellular protein ADAMTS-like 2 regulates differentiation of skeletal muscle-resident fibro-adipogenic progenitor cells. iScience 28 (6), 112712 (2025).","journal-title":"iScience"},{"issue":"1","key":"58527_CR54","doi-asserted-by":"publisher","first-page":"21364","DOI":"10.1038\/s41598-020-78206-4","volume":"10","author":"SW Clayton","year":"2020","unstructured":"Clayton, S. W., Ban, G. I., Liu, C. & Serra, R. Canonical and noncanonical TGF-\u03b2 signaling regulate fibrous tissue differentiation in the axial skeleton. Sci. Rep. 10 (1), 21364 (2020).","journal-title":"Sci. Rep."},{"issue":"5","key":"58527_CR55","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1002\/jbmr.4799","volume":"38","author":"D Batkovskyte","year":"2023","unstructured":"Batkovskyte, D. et al. Al-Gazali skeletal dysplasia constitutes the lethal end of ADAMTSL2-related disorders. J. Bone Min. Res. 38 (5), 692\u2013706 (2023).","journal-title":"J. Bone Min. Res."},{"issue":"3","key":"58527_CR56","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1038\/ng1116","volume":"33","author":"ER Neptune","year":"2003","unstructured":"Neptune, E. R. et al. Dysregulation of TGF-beta activation contributes to pathogenesis in Marfan syndrome. Nat. Genet. 33 (3), 407\u2013411 (2003).","journal-title":"Nat. Genet."},{"issue":"6","key":"58527_CR57","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1002\/humu.22977","volume":"37","author":"A Verstraeten","year":"2016","unstructured":"Verstraeten, A., Alaerts, M., Van Laer, L. & Loeys, B. Marfan syndrome and related disorders: 25 years of gene discovery. Hum. Mutat. 37 (6), 524\u2013531 (2016).","journal-title":"Hum. Mutat."},{"key":"58527_CR58","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/S0065-3233(05)70012-7","volume":"70","author":"CM Kielty","year":"2005","unstructured":"Kielty, C. M., Sherratt, M. J., Marson, A. & Baldock, C. Fibrillin microfibrils. Adv. Protein Chem. 70, 405\u2013436 (2005).","journal-title":"Adv. Protein Chem."},{"issue":"45","key":"58527_CR59","doi-asserted-by":"publisher","first-page":"3491","DOI":"10.1093\/eurheartj\/eht334","volume":"34","author":"M Groenink","year":"2013","unstructured":"Groenink, M. et al. Losartan reduces aortic dilatation rate in adults with Marfan syndrome: a randomized controlled trial. Eur. Heart J. 34 (45), 3491\u20133500 (2013).","journal-title":"Eur. Heart J."},{"key":"58527_CR60","doi-asserted-by":"crossref","unstructured":"Chiu, H. H. et al. Losartan added to \u03b2-blockade therapy for aortic root dilation in Marfan syndrome: a randomized, open-label pilot study. Mayo Clin. Proc. 88 (3), 271\u2013276 (2013).","DOI":"10.1016\/j.mayocp.2012.11.005"},{"issue":"22","key":"58527_CR61","doi-asserted-by":"publisher","first-page":"2061","DOI":"10.1056\/NEJMoa1404731","volume":"371","author":"RV Lacro","year":"2014","unstructured":"Lacro, R. V. et al. Pediatric Heart Network Investigators. Atenolol versus losartan in children and young adults with Marfan\u2019s syndrome. N Engl. J. Med. 371 (22), 2061\u20132071 (2014).","journal-title":"N Engl. J. Med."},{"issue":"12","key":"58527_CR62","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1093\/eurheartj\/ehv575","volume":"37","author":"A Forteza","year":"2016","unstructured":"Forteza, A. et al. Efficacy of losartan vs. atenolol for the prevention of aortic dilation in Marfan syndrome: a randomized clinical trial. Eur. Heart J. 37 (12), 978\u2013985 (2016).","journal-title":"Eur. Heart J."},{"issue":"32","key":"58527_CR63","doi-asserted-by":"publisher","first-page":"2160","DOI":"10.1093\/eurheartj\/ehv151","volume":"36","author":"O Milleron","year":"2015","unstructured":"Milleron, O. et al. Marfan Sartan: a randomized, double-blind, placebo-controlled trial. Eur. Heart J. 36 (32), 2160\u20132166 (2015).","journal-title":"Eur. Heart J."},{"issue":"3","key":"58527_CR64","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1016\/j.ajpath.2017.11.006","volume":"188","author":"SL Sellers","year":"2018","unstructured":"Sellers, S. L. et al. Inhibition of Marfan syndrome aortic root dilation by Losartan: role of angiotensin II receptor type 1-independent activation of endothelial function. Am. J. Pathol. 188 (3), 574\u2013585 (2018).","journal-title":"Am. J. Pathol."},{"issue":"43","key":"58527_CR65","doi-asserted-by":"publisher","first-page":"4181","DOI":"10.1093\/eurheartj\/ehaa377","volume":"41","author":"MM van Andel","year":"2020","unstructured":"van Andel, M. M. et al. Long-term clinical outcomes of losartan in patients with Marfan syndrome: follow-up of the multicentre randomized controlled COMPARE trial. Eur. Heart J. 41 (43), 4181\u20134187 (2020).","journal-title":"Eur. Heart J."},{"key":"58527_CR66","doi-asserted-by":"crossref","unstructured":"Franco-Barraza, J., Beacham, D. A., Amatangelo, M. D. & Cukierman, E. Preparation of extracellular matrices produced by cultured and primary fibroblasts. Curr. Protoc. Cell. Biol. 71, 10.9.1\u201310.9.34 (2016).","DOI":"10.1002\/cpcb.2"},{"key":"58527_CR67","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","volume":"29","author":"A Dobin","year":"2012","unstructured":"Dobin, A. et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29, 15\u201321 (2012).","journal-title":"Bioinformatics"},{"key":"58527_CR68","doi-asserted-by":"publisher","first-page":"3047","DOI":"10.1093\/bioinformatics\/btw354","volume":"32","author":"P Ewels","year":"2016","unstructured":"Ewels, P., Magnusson, M., Lundin, S. & K\u00e4ller, M. MultiQC: summarize analysis results for multiple tools and samples in a single report. Bioinformatics 32, 3047\u20133048 (2016).","journal-title":"Bioinformatics"},{"key":"58527_CR69","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1186\/1471-2105-11-422","volume":"11","author":"TJ Hardcastle","year":"2010","unstructured":"Hardcastle, T. J. & Kelly, K. A.  baySeq: empirical Bayesian methods for identifying differential expression in sequence count data. BMC Bioinform. 11, 422 (2010).","journal-title":"BMC Bioinform."},{"key":"58527_CR70","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014).","journal-title":"Genome Biol."},{"key":"58527_CR71","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1093\/bioinformatics\/btp616","volume":"26","author":"MD Robinson","year":"2009","unstructured":"Robinson, M. D., McCarthy, D. J. & Smyth, G. K. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics 26, 139\u2013140 (2009).","journal-title":"Bioinformatics"},{"key":"58527_CR72","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1186\/s12859-018-2486-6","volume":"19","author":"SX Ge","year":"2018","unstructured":"Ge, S. X., Son, E. W. & Yao, R. iDEP: an integrated web application for differential expression and pathway analysis of RNA-Seq data. BMC Bioinform. 19, 534 (2018).","journal-title":"BMC Bioinform."},{"issue":"43","key":"58527_CR73","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian, A. et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. USA. 102 (43), 15545\u201315550 (2005).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"3","key":"58527_CR74","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1038\/ng1180","volume":"34","author":"VK Mootha","year":"2003","unstructured":"Mootha, V. K. et al. PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat. Genet. 34 (3), 267\u2013273 (2003).","journal-title":"Nat. Genet."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-58527-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-58527-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-58527-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T00:03:32Z","timestamp":1789430612000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-58527-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,23]]},"references-count":74,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["58527"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-58527-6","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-8301608\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,23]]},"assertion":[{"value":"7 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"28645"}}